1-5 of 5
Edo Vellenga
Close
Sort by
Journal Articles

Clonal hematopoiesis in patients with stem cell mobilization failure: a nested case-control study

Carin L. E. Hazenberg, Aniek O. de Graaf, René Mulder, Laura B. Bungener, Maaike G. J. M. van Bergen, André B. Mulder, Goda Choi, Jan Jacob Schuringa, Marco R. de Groot, Edo Vellenga, Joop H. Jansen, Gerwin Huls, Isabelle A. van Zeventer
Journal: Blood Advances
Blood Adv (2023) 7 (7): 1269–1278.
https://doi.org/10.1182/bloodadvances.2022007497
Published: 2023
Includes: Supplemental data
Journal Articles

Peripheral blood cytopenias in the aging general population and risk of incident hematological disease and mortality

Clinical Trials & Observations
Isabelle A. van Zeventer, Aniek O. de Graaf, Melanie M. van der Klauw, Edo Vellenga, Bert A. van der Reijden, Jan Jacob Schuringa, Arjan Diepstra, Luca Malcovati, Joop H. Jansen, Gerwin Huls
Journal: Blood Advances
Blood Adv (2021) 5 (17): 3266–3278.
https://doi.org/10.1182/bloodadvances.2021004355
Published: 2021
Includes: Supplemental data
Journal Articles

Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trial

Clinical Trials & Observations
Bob Löwenberg, Thomas Pabst, Johan Maertens, Patrycja Gradowska, Bart J. Biemond, Olivier Spertini, Edo Vellenga, Laimonas Griskevicius, Lidwine W. Tick, Mojca Jongen-Lavrencic, Marinus van Marwijk Kooy, Marie-Christiane Vekemans, Walter J. F. M. van der Velden, Berna Beverloo, Lucienne Michaux, Carlos Graux, Dries Deeren, Okke de Weerdt, Joost W. J. van Esser, Mario Bargetzi, Saskia K. Klein, Alain Gadisseur, Peter E. Westerweel, Hendrik Veelken, Michael Gregor, Tobias Silzle, Daniëlle van Lammeren-Venema, Ine Moors, Dimitri A. Breems, Mels Hoogendoorn, Marie-Cecile J. C. Legdeur, Thomas Fischer, Juergen Kuball, Jan Cornelissen, Kimmo Porkka, Gunnar Juliusson, Peter Meyer, Martin Höglund, Bjorn T. Gjertsen, Jeroen J. W. M. Janssen, Gerwin Huls, Jakob Passweg, Jacqueline Cloos, Peter J. M. Valk, Catharina H. M. J. van Elssen, Markus G. Manz, Yngvar Floisand, Gert J. Ossenkoppele
Journal: Blood Advances
Blood Adv (2021) 5 (4): 1110–1121.
https://doi.org/10.1182/bloodadvances.2020003855
Published: 2021
Includes: Supplemental data
Journal Articles

Ring sideroblasts in AML are associated with adverse risk characteristics and have a distinct gene expression pattern

Gerbrig Berger, Mylene Gerritsen, Guoqiang Yi, Theresia N. Koorenhof-Scheele, Leonie I. Kroeze, Marian Stevens-Kroef, Kenichi Yoshida, Yuichi Shiraishi, Eva van den Berg, Hein Schepers, Geert Huls, André B. Mulder, Seishi Ogawa, Joost H. A. Martens, Joop H. Jansen, Edo Vellenga
Journal: Blood Advances
Blood Adv (2019) 3 (20): 3111–3122.
https://doi.org/10.1182/bloodadvances.2019000518
Published: 2019
Includes: Supplemental data
Journal Articles

RUNX1 mutations enhance self-renewal and block granulocytic differentiation in human in vitro models and primary AMLs

Mylène Gerritsen, Guoqiang Yi, Esther Tijchon, Jorren Kuster, Jan Jacob Schuringa, Joost H. A. Martens, Edo Vellenga
Journal: Blood Advances
Blood Adv (2019) 3 (3): 320–332.
https://doi.org/10.1182/bloodadvances.2018024422
Published: 2019
Includes: Supplemental data